Bellicum Pharmaceuticals: Q2 Earnings Snapshot

August 11, 2022 GMT

HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Thursday reported a loss of $4 million in its second quarter.

On a per-share basis, the Houston-based company said it had a loss of 13 cents.

In the final minutes of trading on Thursday, the company’s shares hit $1.42. A year ago, they were trading at $3.05.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on BLCM at